Industry Symposium by Canon Medical

IND 21 - CT & MRI Screening and Follow-up: What’s New

The European Union Council recently adopted a new approach to cancer screening, following the Commission's proposal to boost cancer prevention through early diagnosis. This is an important step in improving early detection throughout the EU, which is a fundamental goal of Europe's Beating Cancer Plan. The new strategy calls for gradually expanding population–based screening programs to include prostate and lung. *

This Symposium will concentrate on CT screening for lung cancer and MRI screening for prostate cancer.
  • Learn about Canon Medical's new CT scanner and why it is ideal for lung cancer screening.
  • Understand the evolution of AI in prostate MRI and its impact on clinical practice. How might AI help with prostate cancer screening by employing MRI as a supporting imaging modality?


* https://ec.europa.eu/commission/presscorner/detail/en/ip_22_5562
5 min
Introduction
20 min
Harnessing the Power of Automation in CT to Serve Screening Purposes
Russell Bull, Bournemouth / United Kingdom
Learning Objectives
Although CT of the thorax is a well-established technology, it has limited use in particular populations, such as younger patients, due to radiation dosage issues. Because of the use of silver filtration, CT may be conducted at dosages comparable to plain film while delivering far more diagnostic information. There will be demonstrations of image quality and radiation exposures utilizing a new CT scanner, the Aquilion Serve. In addition, the system’s latest technologies that harness the power of automation in the workflow will be discussed.
20 min
AI in Prostate MRI: Current Applications and Perspectives
Pierre Leyendecker, Strasbourg, France / France
Learning Objectives
Magnetic Resonance Imaging (MRI) offers reliable visualization of potentially significant prostate cancers and thus has shown advantages as a means by which to better select patients for biopsy and facilitate direct targeting of lesions during biopsy. Major technical improvements in multiparametric prostate MRI with the standard approach to interpretation using the prostate imaging reporting and data system version 2.1 (PI-RADS v2.1) have rapidly expanded the role of MRI in prostate cancer management in many clinical contexts, both prior to and following diagnosis. This presentation will deal with the development of AI in prostate MRI and its contribution in clinical routine.
15 min
Summary and perspective

Lectures

1
Introduction

Introduction

05:00Stefan Niehues, Berlin / DE

2
Harnessing the Power of Automation in CT to Serve Screening Purposes

Harnessing the Power of Automation in CT to Serve Screening Purposes

20:00Russell Bull, Bournemouth / UK

3
AI in prostate MRI: current applications and perspectives

AI in prostate MRI: current applications and perspectives

20:00Pierre Leyendecker, Strasbourg, France / FR